nodes	percent_of_prediction	percent_of_DWPC	metapath
Prochlorperazine—CYP3A4—Temozolomide—melanoma	0.172	0.385	CbGbCtD
Prochlorperazine—CYP2D6—Vemurafenib—melanoma	0.148	0.332	CbGbCtD
Prochlorperazine—CYP3A4—Vemurafenib—melanoma	0.0944	0.211	CbGbCtD
Prochlorperazine—CYP3A4—Docetaxel—melanoma	0.0324	0.0724	CbGbCtD
Prochlorperazine—Abnormal pigmentation—Temozolomide—melanoma	0.0315	0.0887	CcSEcCtD
Prochlorperazine—Edema cerebral—Carmustine—melanoma	0.0198	0.0559	CcSEcCtD
Prochlorperazine—Edema cerebral—Temozolomide—melanoma	0.0192	0.0541	CcSEcCtD
Prochlorperazine—Brain oedema—Carmustine—melanoma	0.0107	0.0303	CcSEcCtD
Prochlorperazine—Brain oedema—Temozolomide—melanoma	0.0104	0.0293	CcSEcCtD
Prochlorperazine—Pigmentation disorder—Temozolomide—melanoma	0.00888	0.025	CcSEcCtD
Prochlorperazine—Clobazam—SLC6A11—melanoma	0.00761	0.567	CrCbGaD
Prochlorperazine—Altered state of consciousness—Temozolomide—melanoma	0.00642	0.0181	CcSEcCtD
Prochlorperazine—Eruption—Dactinomycin—melanoma	0.00533	0.015	CcSEcCtD
Prochlorperazine—Deep vein thrombosis—Temozolomide—melanoma	0.00487	0.0137	CcSEcCtD
Prochlorperazine—Photosensitivity—Vemurafenib—melanoma	0.0048	0.0135	CcSEcCtD
Prochlorperazine—Extrapyramidal disorder—Temozolomide—melanoma	0.00394	0.0111	CcSEcCtD
Prochlorperazine—Cholestasis—Temozolomide—melanoma	0.0039	0.011	CcSEcCtD
Prochlorperazine—Eosinophilia—Vemurafenib—melanoma	0.0036	0.0102	CcSEcCtD
Prochlorperazine—Menstruation irregular—Docetaxel—melanoma	0.00356	0.01	CcSEcCtD
Prochlorperazine—Systemic lupus erythematosus—Docetaxel—melanoma	0.00356	0.01	CcSEcCtD
Prochlorperazine—Liver injury—Temozolomide—melanoma	0.00352	0.00994	CcSEcCtD
Prochlorperazine—Amenorrhoea—Temozolomide—melanoma	0.00337	0.00952	CcSEcCtD
Prochlorperazine—Photosensitivity reaction—Vemurafenib—melanoma	0.00332	0.00937	CcSEcCtD
Prochlorperazine—Deep vein thrombosis—Docetaxel—melanoma	0.00324	0.00914	CcSEcCtD
Prochlorperazine—Eruption—Docetaxel—melanoma	0.00321	0.00904	CcSEcCtD
Prochlorperazine—Gait disturbance—Carmustine—melanoma	0.00314	0.00887	CcSEcCtD
Prochlorperazine—Aplastic anaemia—Dactinomycin—melanoma	0.00308	0.00868	CcSEcCtD
Prochlorperazine—Pulmonary embolism—Carmustine—melanoma	0.00307	0.00865	CcSEcCtD
Prochlorperazine—Gait disturbance—Temozolomide—melanoma	0.00304	0.00857	CcSEcCtD
Prochlorperazine—Pulmonary embolism—Temozolomide—melanoma	0.00297	0.00836	CcSEcCtD
Prochlorperazine—Oedema peripheral—Vemurafenib—melanoma	0.00287	0.00809	CcSEcCtD
Prochlorperazine—Coma—Carmustine—melanoma	0.0028	0.00791	CcSEcCtD
Prochlorperazine—Aplastic anaemia—Temozolomide—melanoma	0.00278	0.00785	CcSEcCtD
Prochlorperazine—Erythema multiforme—Vemurafenib—melanoma	0.00275	0.00777	CcSEcCtD
Prochlorperazine—Gynaecomastia—Carmustine—melanoma	0.00275	0.00774	CcSEcCtD
Prochlorperazine—Throat sore—Docetaxel—melanoma	0.00274	0.00771	CcSEcCtD
Prochlorperazine—Oropharyngeal discomfort—Docetaxel—melanoma	0.00271	0.00765	CcSEcCtD
Prochlorperazine—Erythema—Vemurafenib—melanoma	0.00254	0.00715	CcSEcCtD
Prochlorperazine—Nasal congestion—Temozolomide—melanoma	0.00236	0.00666	CcSEcCtD
Prochlorperazine—Dermatitis exfoliative—Temozolomide—melanoma	0.00228	0.00643	CcSEcCtD
Prochlorperazine—Amenorrhoea—Docetaxel—melanoma	0.00224	0.00633	CcSEcCtD
Prochlorperazine—Cough—Vemurafenib—melanoma	0.00221	0.00624	CcSEcCtD
Prochlorperazine—Oropharyngeal pain—Docetaxel—melanoma	0.00217	0.00611	CcSEcCtD
Prochlorperazine—Pancytopenia—Bleomycin—melanoma	0.00209	0.00591	CcSEcCtD
Prochlorperazine—Anaphylactic shock—Vemurafenib—melanoma	0.00207	0.00584	CcSEcCtD
Prochlorperazine—Dysphagia—Dactinomycin—melanoma	0.00206	0.0058	CcSEcCtD
Prochlorperazine—Infection—Vemurafenib—melanoma	0.00206	0.0058	CcSEcCtD
Prochlorperazine—Skin disorder—Vemurafenib—melanoma	0.00201	0.00567	CcSEcCtD
Prochlorperazine—Hepatocellular injury—Docetaxel—melanoma	0.00197	0.00556	CcSEcCtD
Prochlorperazine—Pulmonary embolism—Docetaxel—melanoma	0.00197	0.00556	CcSEcCtD
Prochlorperazine—Pancytopenia—Dactinomycin—melanoma	0.00195	0.00551	CcSEcCtD
Prochlorperazine—Hypotension—Vemurafenib—melanoma	0.00193	0.00545	CcSEcCtD
Prochlorperazine—Dysphagia—Carmustine—melanoma	0.00193	0.00543	CcSEcCtD
Prochlorperazine—Dysphagia—Temozolomide—melanoma	0.00186	0.00525	CcSEcCtD
Prochlorperazine—Pancytopenia—Carmustine—melanoma	0.00183	0.00516	CcSEcCtD
Prochlorperazine—Constipation—Vemurafenib—melanoma	0.00177	0.00499	CcSEcCtD
Prochlorperazine—Pancytopenia—Temozolomide—melanoma	0.00177	0.00498	CcSEcCtD
Prochlorperazine—Hyperglycaemia—Carmustine—melanoma	0.00174	0.0049	CcSEcCtD
Prochlorperazine—Erectile dysfunction—Temozolomide—melanoma	0.00171	0.00483	CcSEcCtD
Prochlorperazine—Agranulocytosis—Dactinomycin—melanoma	0.00171	0.00483	CcSEcCtD
Prochlorperazine—Photosensitivity reaction—Temozolomide—melanoma	0.0017	0.00479	CcSEcCtD
Prochlorperazine—Weight increased—Temozolomide—melanoma	0.00169	0.00477	CcSEcCtD
Prochlorperazine—Hyperglycaemia—Temozolomide—melanoma	0.00168	0.00473	CcSEcCtD
Prochlorperazine—Body temperature increased—Vemurafenib—melanoma	0.00164	0.00461	CcSEcCtD
Prochlorperazine—Erythema multiforme—Dactinomycin—melanoma	0.00156	0.00439	CcSEcCtD
Prochlorperazine—Erythema—Bleomycin—melanoma	0.00154	0.00433	CcSEcCtD
Prochlorperazine—Hypersensitivity—Vemurafenib—melanoma	0.00153	0.0043	CcSEcCtD
Prochlorperazine—Oedema peripheral—Carmustine—melanoma	0.00152	0.00428	CcSEcCtD
Prochlorperazine—Oedema peripheral—Temozolomide—melanoma	0.00147	0.00414	CcSEcCtD
Prochlorperazine—Pruritus—Vemurafenib—melanoma	0.00146	0.00413	CcSEcCtD
Prochlorperazine—Erythema—Dactinomycin—melanoma	0.00143	0.00404	CcSEcCtD
Prochlorperazine—Erythema multiforme—Temozolomide—melanoma	0.00141	0.00397	CcSEcCtD
Prochlorperazine—Arrhythmia—Carmustine—melanoma	0.00138	0.00388	CcSEcCtD
Prochlorperazine—Leukopenia—Bleomycin—melanoma	0.00138	0.00388	CcSEcCtD
Prochlorperazine—Dizziness—Vemurafenib—melanoma	0.00137	0.00386	CcSEcCtD
Prochlorperazine—Erythema—Carmustine—melanoma	0.00134	0.00378	CcSEcCtD
Prochlorperazine—Cough—Bleomycin—melanoma	0.00134	0.00378	CcSEcCtD
Prochlorperazine—Rash—Vemurafenib—melanoma	0.00131	0.00368	CcSEcCtD
Prochlorperazine—Dermatitis—Vemurafenib—melanoma	0.0013	0.00368	CcSEcCtD
Prochlorperazine—Headache—Vemurafenib—melanoma	0.0013	0.00366	CcSEcCtD
Prochlorperazine—Erythema—Temozolomide—melanoma	0.0013	0.00366	CcSEcCtD
Prochlorperazine—Leukopenia—Dactinomycin—melanoma	0.00128	0.00362	CcSEcCtD
Prochlorperazine—Vision blurred—Carmustine—melanoma	0.00126	0.00356	CcSEcCtD
Prochlorperazine—Tremor—Carmustine—melanoma	0.00126	0.00354	CcSEcCtD
Prochlorperazine—Anaphylactic shock—Bleomycin—melanoma	0.00125	0.00354	CcSEcCtD
Prochlorperazine—Oedema—Bleomycin—melanoma	0.00125	0.00354	CcSEcCtD
Prochlorperazine—Infection—Bleomycin—melanoma	0.00125	0.00351	CcSEcCtD
Prochlorperazine—Dysphagia—Docetaxel—melanoma	0.00124	0.00349	CcSEcCtD
Prochlorperazine—Agitation—Carmustine—melanoma	0.00123	0.00348	CcSEcCtD
Prochlorperazine—Thrombocytopenia—Bleomycin—melanoma	0.00123	0.00346	CcSEcCtD
Prochlorperazine—Vision blurred—Temozolomide—melanoma	0.00122	0.00344	CcSEcCtD
Prochlorperazine—Tremor—Temozolomide—melanoma	0.00121	0.00342	CcSEcCtD
Prochlorperazine—Leukopenia—Carmustine—melanoma	0.0012	0.00339	CcSEcCtD
Prochlorperazine—Agitation—Temozolomide—melanoma	0.00119	0.00336	CcSEcCtD
Prochlorperazine—Angioedema—Temozolomide—melanoma	0.00118	0.00334	CcSEcCtD
Prochlorperazine—Pancytopenia—Docetaxel—melanoma	0.00117	0.00331	CcSEcCtD
Prochlorperazine—Hypotension—Bleomycin—melanoma	0.00117	0.0033	CcSEcCtD
Prochlorperazine—Oedema—Dactinomycin—melanoma	0.00117	0.0033	CcSEcCtD
Prochlorperazine—Convulsion—Carmustine—melanoma	0.00116	0.00328	CcSEcCtD
Prochlorperazine—Infection—Dactinomycin—melanoma	0.00116	0.00328	CcSEcCtD
Prochlorperazine—Leukopenia—Temozolomide—melanoma	0.00116	0.00327	CcSEcCtD
Prochlorperazine—Thrombocytopenia—Dactinomycin—melanoma	0.00115	0.00323	CcSEcCtD
Prochlorperazine—Cough—Temozolomide—melanoma	0.00113	0.00319	CcSEcCtD
Prochlorperazine—Weight increased—Docetaxel—melanoma	0.00113	0.00317	CcSEcCtD
Prochlorperazine—Convulsion—Temozolomide—melanoma	0.00112	0.00317	CcSEcCtD
Prochlorperazine—Dyspnoea—Bleomycin—melanoma	0.00112	0.00315	CcSEcCtD
Prochlorperazine—Oedema—Carmustine—melanoma	0.00109	0.00309	CcSEcCtD
Prochlorperazine—Infection—Carmustine—melanoma	0.00109	0.00307	CcSEcCtD
Prochlorperazine—Dry mouth—Temozolomide—melanoma	0.00108	0.00304	CcSEcCtD
Prochlorperazine—Jaundice—Docetaxel—melanoma	0.00108	0.00303	CcSEcCtD
Prochlorperazine—Thrombocytopenia—Carmustine—melanoma	0.00107	0.00302	CcSEcCtD
Prochlorperazine—Anaphylactic shock—Temozolomide—melanoma	0.00106	0.00298	CcSEcCtD
Prochlorperazine—Oedema—Temozolomide—melanoma	0.00106	0.00298	CcSEcCtD
Prochlorperazine—Infection—Temozolomide—melanoma	0.00105	0.00296	CcSEcCtD
Prochlorperazine—Thrombocytopenia—Temozolomide—melanoma	0.00104	0.00292	CcSEcCtD
Prochlorperazine—Agranulocytosis—Docetaxel—melanoma	0.00103	0.0029	CcSEcCtD
Prochlorperazine—Skin disorder—Temozolomide—melanoma	0.00103	0.0029	CcSEcCtD
Prochlorperazine—Hypotension—Carmustine—melanoma	0.00102	0.00288	CcSEcCtD
Prochlorperazine—Urticaria—Bleomycin—melanoma	0.000996	0.00281	CcSEcCtD
Prochlorperazine—Body temperature increased—Bleomycin—melanoma	0.000991	0.0028	CcSEcCtD
Prochlorperazine—Insomnia—Carmustine—melanoma	0.00099	0.00279	CcSEcCtD
Prochlorperazine—Dyspnoea—Carmustine—melanoma	0.000976	0.00275	CcSEcCtD
Prochlorperazine—Oedema peripheral—Docetaxel—melanoma	0.000975	0.00275	CcSEcCtD
Prochlorperazine—Somnolence—Carmustine—melanoma	0.000973	0.00274	CcSEcCtD
Prochlorperazine—Insomnia—Temozolomide—melanoma	0.000957	0.0027	CcSEcCtD
Prochlorperazine—Dyspnoea—Temozolomide—melanoma	0.000943	0.00266	CcSEcCtD
Prochlorperazine—Somnolence—Temozolomide—melanoma	0.00094	0.00265	CcSEcCtD
Prochlorperazine—Erythema multiforme—Docetaxel—melanoma	0.000936	0.00264	CcSEcCtD
Prochlorperazine—Constipation—Carmustine—melanoma	0.000936	0.00264	CcSEcCtD
Prochlorperazine—Body temperature increased—Dactinomycin—melanoma	0.000925	0.00261	CcSEcCtD
Prochlorperazine—Hypersensitivity—Bleomycin—melanoma	0.000924	0.00261	CcSEcCtD
Prochlorperazine—Constipation—Temozolomide—melanoma	0.000905	0.00255	CcSEcCtD
Prochlorperazine—Pruritus—Bleomycin—melanoma	0.000887	0.0025	CcSEcCtD
Prochlorperazine—Arrhythmia—Docetaxel—melanoma	0.000885	0.00249	CcSEcCtD
Prochlorperazine—Body temperature increased—Carmustine—melanoma	0.000865	0.00244	CcSEcCtD
Prochlorperazine—Erythema—Docetaxel—melanoma	0.000862	0.00243	CcSEcCtD
Prochlorperazine—Hypersensitivity—Dactinomycin—melanoma	0.000862	0.00243	CcSEcCtD
Prochlorperazine—Urticaria—Temozolomide—melanoma	0.00084	0.00237	CcSEcCtD
Prochlorperazine—Body temperature increased—Temozolomide—melanoma	0.000836	0.00236	CcSEcCtD
Prochlorperazine—Muscle spasms—Docetaxel—melanoma	0.000829	0.00234	CcSEcCtD
Prochlorperazine—Hypersensitivity—Carmustine—melanoma	0.000807	0.00227	CcSEcCtD
Prochlorperazine—Rash—Bleomycin—melanoma	0.000791	0.00223	CcSEcCtD
Prochlorperazine—Dermatitis—Bleomycin—melanoma	0.00079	0.00223	CcSEcCtD
Prochlorperazine—Hypersensitivity—Temozolomide—melanoma	0.000779	0.0022	CcSEcCtD
Prochlorperazine—Leukopenia—Docetaxel—melanoma	0.000772	0.00218	CcSEcCtD
Prochlorperazine—Cough—Docetaxel—melanoma	0.000752	0.00212	CcSEcCtD
Prochlorperazine—Pruritus—Temozolomide—melanoma	0.000748	0.00211	CcSEcCtD
Prochlorperazine—Convulsion—Docetaxel—melanoma	0.000747	0.00211	CcSEcCtD
Prochlorperazine—Rash—Dactinomycin—melanoma	0.000737	0.00208	CcSEcCtD
Prochlorperazine—Dizziness—Carmustine—melanoma	0.000724	0.00204	CcSEcCtD
Prochlorperazine—Dry mouth—Docetaxel—melanoma	0.000718	0.00202	CcSEcCtD
Prochlorperazine—Anaphylactic shock—Docetaxel—melanoma	0.000704	0.00198	CcSEcCtD
Prochlorperazine—Oedema—Docetaxel—melanoma	0.000704	0.00198	CcSEcCtD
Prochlorperazine—Dizziness—Temozolomide—melanoma	0.0007	0.00197	CcSEcCtD
Prochlorperazine—Infection—Docetaxel—melanoma	0.000699	0.00197	CcSEcCtD
Prochlorperazine—Rash—Carmustine—melanoma	0.00069	0.00195	CcSEcCtD
Prochlorperazine—Dermatitis—Carmustine—melanoma	0.00069	0.00194	CcSEcCtD
Prochlorperazine—Thrombocytopenia—Docetaxel—melanoma	0.000689	0.00194	CcSEcCtD
Prochlorperazine—Headache—Carmustine—melanoma	0.000686	0.00193	CcSEcCtD
Prochlorperazine—Skin disorder—Docetaxel—melanoma	0.000683	0.00193	CcSEcCtD
Prochlorperazine—Rash—Temozolomide—melanoma	0.000667	0.00188	CcSEcCtD
Prochlorperazine—Dermatitis—Temozolomide—melanoma	0.000666	0.00188	CcSEcCtD
Prochlorperazine—Headache—Temozolomide—melanoma	0.000663	0.00187	CcSEcCtD
Prochlorperazine—Hypotension—Docetaxel—melanoma	0.000657	0.00185	CcSEcCtD
Prochlorperazine—Insomnia—Docetaxel—melanoma	0.000636	0.00179	CcSEcCtD
Prochlorperazine—Dyspnoea—Docetaxel—melanoma	0.000627	0.00177	CcSEcCtD
Prochlorperazine—Somnolence—Docetaxel—melanoma	0.000625	0.00176	CcSEcCtD
Prochlorperazine—Constipation—Docetaxel—melanoma	0.000602	0.0017	CcSEcCtD
Prochlorperazine—Body temperature increased—Docetaxel—melanoma	0.000556	0.00157	CcSEcCtD
Prochlorperazine—Clozapine—CYP1B1—melanoma	0.00055	0.0409	CrCbGaD
Prochlorperazine—Hypersensitivity—Docetaxel—melanoma	0.000518	0.00146	CcSEcCtD
Prochlorperazine—Pruritus—Docetaxel—melanoma	0.000498	0.0014	CcSEcCtD
Prochlorperazine—Dizziness—Docetaxel—melanoma	0.000465	0.00131	CcSEcCtD
Prochlorperazine—Rash—Docetaxel—melanoma	0.000444	0.00125	CcSEcCtD
Prochlorperazine—Dermatitis—Docetaxel—melanoma	0.000443	0.00125	CcSEcCtD
Prochlorperazine—Headache—Docetaxel—melanoma	0.000441	0.00124	CcSEcCtD
Prochlorperazine—Domperidone—ABCB1—melanoma	0.00038	0.0283	CrCbGaD
Prochlorperazine—Nefazodone—ABCB1—melanoma	0.000316	0.0235	CrCbGaD
Prochlorperazine—Triflupromazine—ABCB1—melanoma	0.000308	0.0229	CrCbGaD
Prochlorperazine—Acepromazine—ALB—melanoma	0.000298	0.0222	CrCbGaD
Prochlorperazine—Aripiprazole—ABCB1—melanoma	0.000293	0.0219	CrCbGaD
Prochlorperazine—Trazodone—ABCB1—melanoma	0.000292	0.0217	CrCbGaD
Prochlorperazine—Thioproperazine—ALB—melanoma	0.000292	0.0217	CrCbGaD
Prochlorperazine—Thiothixene—ALB—melanoma	0.000287	0.0214	CrCbGaD
Prochlorperazine—Pipotiazine—ALB—melanoma	0.000287	0.0214	CrCbGaD
Prochlorperazine—Clobazam—ABCB1—melanoma	0.000274	0.0204	CrCbGaD
Prochlorperazine—Fluphenazine—ABCB1—melanoma	0.000237	0.0176	CrCbGaD
Prochlorperazine—Clomipramine—ALB—melanoma	0.000227	0.0169	CrCbGaD
Prochlorperazine—Clomipramine—ABCB1—melanoma	0.000216	0.0161	CrCbGaD
Prochlorperazine—Chlorprothixene—ABCB1—melanoma	0.000215	0.016	CrCbGaD
Prochlorperazine—Promethazine—ABCB1—melanoma	0.000192	0.0143	CrCbGaD
Prochlorperazine—Trifluoperazine—ABCB1—melanoma	0.000189	0.0141	CrCbGaD
Prochlorperazine—Quetiapine—ABCB1—melanoma	0.000183	0.0137	CrCbGaD
Prochlorperazine—Desipramine—ABCB1—melanoma	0.000174	0.013	CrCbGaD
Prochlorperazine—Clozapine—ABCB1—melanoma	0.000158	0.0117	CrCbGaD
Prochlorperazine—Chlorpromazine—ALB—melanoma	0.000156	0.0116	CrCbGaD
Prochlorperazine—Chlorpromazine—ABCB1—melanoma	0.000148	0.011	CrCbGaD
Prochlorperazine—Imipramine—ABCB1—melanoma	0.000148	0.011	CrCbGaD
Prochlorperazine—HTR2C—Signaling Pathways—BRAF—melanoma	2.4e-05	0.00013	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—KDR—melanoma	2.36e-05	0.000128	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—FN1—melanoma	2.35e-05	0.000128	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—IGF1—melanoma	2.34e-05	0.000127	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling by GPCR—PIK3CA—melanoma	2.33e-05	0.000126	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling by GPCR—MAPK1—melanoma	2.33e-05	0.000126	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling by GPCR—EGFR—melanoma	2.33e-05	0.000126	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—MDM2—melanoma	2.32e-05	0.000126	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—FN1—melanoma	2.31e-05	0.000125	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—NOTCH1—melanoma	2.3e-05	0.000125	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—ERBB2—melanoma	2.29e-05	0.000124	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—FN1—melanoma	2.27e-05	0.000123	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—NOTCH1—melanoma	2.26e-05	0.000123	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—MAP2K1—melanoma	2.26e-05	0.000123	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—CD80—melanoma	2.26e-05	0.000122	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—PIK3CB—melanoma	2.26e-05	0.000122	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—PIK3CG—melanoma	2.25e-05	0.000122	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—KIT—melanoma	2.25e-05	0.000122	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—APC—melanoma	2.25e-05	0.000122	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling by GPCR—NRAS—melanoma	2.25e-05	0.000122	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—PIK3CD—melanoma	2.24e-05	0.000122	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—EGF—melanoma	2.23e-05	0.000121	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—NOTCH1—melanoma	2.23e-05	0.000121	CbGpPWpGaD
Prochlorperazine—HTR2C—GPCR downstream signaling—PIK3CA—melanoma	2.22e-05	0.000121	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—CD80—melanoma	2.22e-05	0.00012	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—APC—melanoma	2.21e-05	0.00012	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—PIK3CG—melanoma	2.21e-05	0.00012	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—KIT—melanoma	2.21e-05	0.00012	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling by GPCR—NRAS—melanoma	2.21e-05	0.00012	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling by GPCR—KRAS—melanoma	2.2e-05	0.000119	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—EGF—melanoma	2.19e-05	0.000119	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—CD80—melanoma	2.18e-05	0.000118	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—ABCB1—melanoma	2.18e-05	0.000118	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—PIK3CG—melanoma	2.18e-05	0.000118	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—APC—melanoma	2.18e-05	0.000118	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—KIT—melanoma	2.18e-05	0.000118	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling by GPCR—NRAS—melanoma	2.18e-05	0.000118	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—CXCL8—melanoma	2.17e-05	0.000118	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling by GPCR—MAPK3—melanoma	2.16e-05	0.000117	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling by GPCR—HRAS—melanoma	2.15e-05	0.000117	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—EGF—melanoma	2.15e-05	0.000117	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—FGF2—melanoma	2.15e-05	0.000117	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling by GPCR—MAPK3—melanoma	2.12e-05	0.000115	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—BRAF—melanoma	2.12e-05	0.000115	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—CDKN1B—melanoma	2.12e-05	0.000115	CbGpPWpGaD
Prochlorperazine—DRD3—GPCR downstream signaling—AKT1—melanoma	2.09e-05	0.000114	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling by GPCR—MAPK3—melanoma	2.08e-05	0.000113	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—BRAF—melanoma	2.08e-05	0.000113	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—CASP3—melanoma	2.08e-05	0.000113	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—IL2—melanoma	2.07e-05	0.000112	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—IGF1—melanoma	2.06e-05	0.000112	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling by GPCR—IL6—melanoma	2.06e-05	0.000112	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—CYP17A1—melanoma	2.06e-05	0.000112	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling by GPCR—MAPK1—melanoma	2.05e-05	0.000111	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling by GPCR—EGFR—melanoma	2.05e-05	0.000111	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—BRAF—melanoma	2.05e-05	0.000111	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—IGF1—melanoma	2.03e-05	0.00011	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—CCND1—melanoma	2.02e-05	0.00011	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling by GPCR—PIK3CA—melanoma	2.02e-05	0.00011	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling by GPCR—MAPK1—melanoma	2.02e-05	0.000109	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling by GPCR—EGFR—melanoma	2.02e-05	0.000109	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—MDM2—melanoma	2.01e-05	0.000109	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—PRKCA—melanoma	2.01e-05	0.000109	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—CTNNB1—melanoma	2e-05	0.000109	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—MAP2K1—melanoma	1.99e-05	0.000108	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—IGF1—melanoma	1.99e-05	0.000108	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—ERCC2—melanoma	1.99e-05	0.000108	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling by GPCR—MAPK1—melanoma	1.98e-05	0.000108	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling by GPCR—EGFR—melanoma	1.98e-05	0.000108	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—ERBB2—melanoma	1.98e-05	0.000108	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—PIK3CD—melanoma	1.98e-05	0.000107	CbGpPWpGaD
Prochlorperazine—DRD2—GPCR downstream signaling—PIK3CA—melanoma	1.96e-05	0.000106	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—MMP9—melanoma	1.96e-05	0.000106	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—MAP2K1—melanoma	1.96e-05	0.000106	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—PIK3CB—melanoma	1.96e-05	0.000106	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—CDKN1A—melanoma	1.95e-05	0.000106	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—PTEN—melanoma	1.95e-05	0.000106	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—PIK3CD—melanoma	1.94e-05	0.000106	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—GNA11—melanoma	1.94e-05	0.000105	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—NFKB1—melanoma	1.94e-05	0.000105	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling by GPCR—KRAS—melanoma	1.94e-05	0.000105	CbGpPWpGaD
Prochlorperazine—HRH1—GPCR downstream signaling—PIK3CA—melanoma	1.93e-05	0.000105	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—MAP2K1—melanoma	1.93e-05	0.000105	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—PIK3CD—melanoma	1.91e-05	0.000104	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling by GPCR—KRAS—melanoma	1.9e-05	0.000103	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling by GPCR—AKT1—melanoma	1.9e-05	0.000103	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—FASN—melanoma	1.9e-05	0.000103	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—FGF2—melanoma	1.9e-05	0.000103	CbGpPWpGaD
Prochlorperazine—CHRM2—GPCR downstream signaling—PIK3CA—melanoma	1.9e-05	0.000103	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—CXCL8—melanoma	1.88e-05	0.000102	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling by GPCR—KRAS—melanoma	1.87e-05	0.000102	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—SLC5A5—melanoma	1.87e-05	0.000101	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling by GPCR—HRAS—melanoma	1.87e-05	0.000101	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—FGF2—melanoma	1.86e-05	0.000101	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—CDKN1B—melanoma	1.84e-05	9.96e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—FGF2—melanoma	1.83e-05	9.94e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—GPCR downstream signaling—AKT1—melanoma	1.82e-05	9.85e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—GNAQ—melanoma	1.81e-05	9.8e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—CD44—melanoma	1.81e-05	9.8e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—CASP3—melanoma	1.8e-05	9.76e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—IL2—melanoma	1.8e-05	9.75e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling by GPCR—IL6—melanoma	1.79e-05	9.7e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling by GPCR—PIK3CA—melanoma	1.78e-05	9.67e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—MDM2—melanoma	1.77e-05	9.63e-05	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—VEGFA—melanoma	1.76e-05	9.55e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—CCND1—melanoma	1.75e-05	9.5e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—ERBB2—melanoma	1.75e-05	9.49e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling by GPCR—PIK3CA—melanoma	1.75e-05	9.49e-05	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—STAT3—melanoma	1.74e-05	9.46e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—MDM2—melanoma	1.74e-05	9.45e-05	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—NRAS—melanoma	1.74e-05	9.44e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—CTNNB1—melanoma	1.73e-05	9.41e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—CYP1B1—melanoma	1.73e-05	9.39e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—PIK3CB—melanoma	1.73e-05	9.37e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling by GPCR—PIK3CA—melanoma	1.72e-05	9.34e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—ERBB2—melanoma	1.72e-05	9.32e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—MDM2—melanoma	1.71e-05	9.3e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—MMP9—melanoma	1.7e-05	9.22e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—PIK3CB—melanoma	1.7e-05	9.2e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—CDKN1A—melanoma	1.69e-05	9.19e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—PTEN—melanoma	1.69e-05	9.17e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—ERBB2—melanoma	1.69e-05	9.17e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—NFKB1—melanoma	1.68e-05	9.13e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—PIK3CB—melanoma	1.67e-05	9.05e-05	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—MAPK3—melanoma	1.67e-05	9.04e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—CXCL8—melanoma	1.66e-05	9e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling by GPCR—AKT1—melanoma	1.65e-05	8.95e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling by GPCR—HRAS—melanoma	1.65e-05	8.94e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—CXCL8—melanoma	1.63e-05	8.84e-05	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—MYC—melanoma	1.62e-05	8.79e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—CDKN1B—melanoma	1.62e-05	8.79e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling by GPCR—HRAS—melanoma	1.62e-05	8.78e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—CXCL8—melanoma	1.6e-05	8.7e-05	CbGpPWpGaD
Prochlorperazine—DRD2—GPCR downstream signaling—AKT1—melanoma	1.6e-05	8.7e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling by GPCR—HRAS—melanoma	1.59e-05	8.64e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—CDKN1B—melanoma	1.59e-05	8.63e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—CASP3—melanoma	1.59e-05	8.62e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—IL2—melanoma	1.59e-05	8.6e-05	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—MAPK1—melanoma	1.59e-05	8.6e-05	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—EGFR—melanoma	1.58e-05	8.6e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling by GPCR—IL6—melanoma	1.58e-05	8.56e-05	CbGpPWpGaD
Prochlorperazine—HRH1—GPCR downstream signaling—AKT1—melanoma	1.57e-05	8.54e-05	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—PIK3CG—melanoma	1.57e-05	8.53e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—CDKN1B—melanoma	1.57e-05	8.49e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—CASP3—melanoma	1.56e-05	8.46e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—IL2—melanoma	1.56e-05	8.45e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling by GPCR—IL6—melanoma	1.55e-05	8.4e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—GPCR downstream signaling—AKT1—melanoma	1.55e-05	8.4e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—CCND1—melanoma	1.55e-05	8.39e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—CASP3—melanoma	1.53e-05	8.32e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—IL2—melanoma	1.53e-05	8.31e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—CTNNB1—melanoma	1.53e-05	8.3e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—VEGFA—melanoma	1.53e-05	8.28e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling by GPCR—IL6—melanoma	1.52e-05	8.27e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—CCND1—melanoma	1.52e-05	8.23e-05	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—PPARG—melanoma	1.52e-05	8.23e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—STAT3—melanoma	1.51e-05	8.2e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—NRAS—melanoma	1.51e-05	8.18e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—CTNNB1—melanoma	1.5e-05	8.15e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—MMP9—melanoma	1.5e-05	8.14e-05	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—KRAS—melanoma	1.5e-05	8.12e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—CDKN1A—melanoma	1.5e-05	8.11e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—CCND1—melanoma	1.49e-05	8.1e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—PTEN—melanoma	1.49e-05	8.09e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—NFKB1—melanoma	1.48e-05	8.05e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—CTNNB1—melanoma	1.48e-05	8.02e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—MMP9—melanoma	1.47e-05	7.99e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—CDKN1A—melanoma	1.47e-05	7.96e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—PTEN—melanoma	1.46e-05	7.95e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—NFKB1—melanoma	1.46e-05	7.91e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling by GPCR—AKT1—melanoma	1.46e-05	7.9e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—MMP9—melanoma	1.45e-05	7.87e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—CDKN1A—melanoma	1.44e-05	7.84e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—MAPK3—melanoma	1.44e-05	7.84e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—PTEN—melanoma	1.44e-05	7.82e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—NFKB1—melanoma	1.43e-05	7.78e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling by GPCR—AKT1—melanoma	1.43e-05	7.75e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—ABCB1—melanoma	1.43e-05	7.73e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling by GPCR—AKT1—melanoma	1.41e-05	7.63e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—MYC—melanoma	1.4e-05	7.62e-05	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—PIK3CD—melanoma	1.38e-05	7.5e-05	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—PIK3CA—melanoma	1.38e-05	7.46e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—MAPK1—melanoma	1.37e-05	7.46e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—EGFR—melanoma	1.37e-05	7.45e-05	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—ALB—melanoma	1.36e-05	7.4e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—VEGFA—melanoma	1.35e-05	7.31e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—STAT3—melanoma	1.33e-05	7.24e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—NRAS—melanoma	1.33e-05	7.22e-05	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—TP53—melanoma	1.33e-05	7.22e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—VEGFA—melanoma	1.32e-05	7.18e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—PRKCA—melanoma	1.31e-05	7.12e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—STAT3—melanoma	1.31e-05	7.11e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—NRAS—melanoma	1.31e-05	7.09e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—VEGFA—melanoma	1.3e-05	7.06e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—ERCC2—melanoma	1.3e-05	7.06e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—KRAS—melanoma	1.3e-05	7.04e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—STAT3—melanoma	1.29e-05	6.99e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—NRAS—melanoma	1.29e-05	6.98e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—MAPK3—melanoma	1.27e-05	6.92e-05	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—HRAS—melanoma	1.27e-05	6.9e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—MAPK3—melanoma	1.25e-05	6.79e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—MYC—melanoma	1.24e-05	6.73e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—MAPK3—melanoma	1.23e-05	6.68e-05	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—IL6—melanoma	1.22e-05	6.61e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—MYC—melanoma	1.22e-05	6.6e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—MAPK1—melanoma	1.21e-05	6.58e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—EGFR—melanoma	1.21e-05	6.58e-05	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—PIK3CB—melanoma	1.2e-05	6.53e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—MYC—melanoma	1.2e-05	6.5e-05	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—PTGS2—melanoma	1.19e-05	6.47e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—PIK3CA—melanoma	1.19e-05	6.47e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—MAPK1—melanoma	1.19e-05	6.46e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—EGFR—melanoma	1.19e-05	6.46e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—MAPK1—melanoma	1.17e-05	6.36e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—EGFR—melanoma	1.17e-05	6.36e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—TP53—melanoma	1.15e-05	6.26e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—KRAS—melanoma	1.15e-05	6.21e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—KRAS—melanoma	1.12e-05	6.1e-05	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—AKT1—melanoma	1.12e-05	6.1e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—KRAS—melanoma	1.11e-05	6e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—HRAS—melanoma	1.1e-05	5.99e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—IL6—melanoma	1.06e-05	5.73e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—PIK3CA—melanoma	1.05e-05	5.71e-05	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—PTEN—melanoma	1.04e-05	5.65e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—PIK3CA—melanoma	1.03e-05	5.61e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—PIK3CG—melanoma	1.03e-05	5.58e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—TP53—melanoma	1.02e-05	5.52e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—PIK3CA—melanoma	1.02e-05	5.52e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—TP53—melanoma	1e-05	5.42e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—PPARG—melanoma	9.92e-06	5.38e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—TP53—melanoma	9.84e-06	5.34e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—AKT1—melanoma	9.74e-06	5.29e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—HRAS—melanoma	9.74e-06	5.28e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—HRAS—melanoma	9.56e-06	5.19e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—HRAS—melanoma	9.41e-06	5.1e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—IL6—melanoma	9.32e-06	5.06e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—IL6—melanoma	9.15e-06	4.96e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—PIK3CD—melanoma	9.03e-06	4.9e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—IL6—melanoma	9e-06	4.88e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—ALB—melanoma	8.92e-06	4.84e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—AKT1—melanoma	8.6e-06	4.66e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—AKT1—melanoma	8.44e-06	4.58e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—AKT1—melanoma	8.31e-06	4.51e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—PIK3CB—melanoma	7.88e-06	4.27e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—PTGS2—melanoma	7.8e-06	4.23e-05	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—PIK3CA—melanoma	7.34e-06	3.98e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—PTEN—melanoma	6.8e-06	3.69e-05	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—AKT1—melanoma	6e-06	3.25e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—PIK3CA—melanoma	4.8e-06	2.6e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—AKT1—melanoma	3.92e-06	2.13e-05	CbGpPWpGaD
